Concepedia
Statistics
Publications
19
Citations
3.2K
H-Index
16
Active since
2000
Affiliations
CureVac (Germany)(Current)
University of Tübingen
Ludwig-Maximilians-Universität München
University Hospital Heidelberg
Heidelberg University
Ingmar Hoerr is an author at CureVac (Germany) specializing in immunology, oncology, and immunotherapy.
Publications per year
2000–2021
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Martin Alberer, Ulrike Gnad-Vogt, Henoch S. Hong et al. · The Lancet · 2017 · 536 citations
Veterinary Medicine, Immunology, Infectious Diseases +15
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Benjamin Weide, Steve Pascolo, Birgit Scheel et al. · Journal of Immunotherapy · 2009 · 380 citations
Medicine, Immunology, Oncology +17
<i>In vivo</i> application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies
Ingmar Hoerr, Reinhard Obst, Hans‐Georg Rammensee et al. · European Journal of Immunology · 2000 · 359 citations
Life Sciences, Immunology, Molecular Biology +16
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt et al. · Journal for ImmunoTherapy of Cancer · 2015 · 284 citations · Full text
Veterinary Medicine, Immunology, Oncology +17
Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
Benjamin Weide, Jean‐Philippe Carralot, Anne Reese et al. · Journal of Immunotherapy · 2008 · 258 citations
1–5 of 19